Effects of sodium butyrate on expression of members of the IGF-binding protein superfamily in human mammary epithelial cells

Journal of Endocrinology

Volumn 169, Issue 1, 2001, Pages 97-110

  Tsubaki, J ^a   Choi, W K ^a   Ingermann, A R ^a   Twigg, S M ^a   Kim, H S ^a   Rosenfeld, R G ^a   Oh, Y ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CELL PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; ESTROGEN; HISTONE; HISTONE DEACETYLASE INHIBITOR; HYDROGEN; MESSENGER RNA; PROTEIN P21; SOMATOMEDIN BINDING PROTEIN; STARCH; THYMIDINE; TRACE ELEMENT;

ACETYLATION; ANAEROBIC BACTERIUM; APOPTOSIS; ARTICLE; BREAST CARCINOMA; BREAST CELL; BREAST EPITHELIUM; CANCER CELL; CANCER PREVENTION; CARCINOGENESIS; CECUM; CELL DIFFERENTIATION; CELL DIVISION; CELL TYPE; COLON; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET; DIETARY FIBER; DIGESTION; DNA SYNTHESIS; EPITHELIUM CELL; GENE ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; MITOSIS INHIBITION; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; STIMULATION;

ACETYLATION; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; BUTYRATES; CELL CYCLE PROTEINS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; ENZYME INHIBITORS; EPITHELIUM; FEMALE; GROWTH SUBSTANCES; HISTONES; HUMANS; IMMEDIATE-EARLY PROTEINS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICRONUTRIENTS; MICROTUBULE-ASSOCIATED PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0035065626     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1690097     Document Type: Article

References (54)

1. Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line
2. Histone acetylation and cancer
3. WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells
4. Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily
5. Induction of the growth inhibitor IGF-binding protein 3 by p53
6. Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas
7. Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate
8. Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3
9. Effect of sodium butyrate on human breast cancer cell lines
10. Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model
11. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor β2-induced growth inhibition in human breast cancer cells
12. Effects of sodium butyrate on the synthesis and methylation of DNA in normal cells and their transformed counterparts
13. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer
14. Bcl-2 and bak may play a pivotal role in sodium butyrate-induced apoptosis in colonic epithelial cells; however overexpression of bcl-2 does not protect against bak-mediated apoptosis
15. Fiber-derived butyrate and the prevention of colon cancer
16. Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7
17. Carboxypeptidase A3 (CPA3): A novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells
18. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age
19. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells
20. Insulin-like growth factor binding proteins: A proposed superfamily
21. Specific proteolytic cleavage of poly (ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis
22. Insulin-like growth factor-binding proteins and their regulatory dynamics
23. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells
24. Direct inhibition of the expression of cyclin D1 gene by sodium butyrate
25. Sodium butyrate induces G2 arrest in the human breast cancer cells MDA-MB-231 and renders them competent for DNA rereplication
26. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE
27. Kip1
28. Insulin-like growth factors and cancer
29. Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells
30. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line
31. Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells
32. Short-chain fatty acids regulate IGF-binding protein secretion by intestinal epithelial cells
33. WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases
34. IGF-independent regulation of breast cancer growth by IGF binding proteins
35. Insulin-like growth factor (IGF)- independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition
36. Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action
37. Role of butyric acid and its derivatives in the treatment of colorectal cancer and hemoglobinopathies
38. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53-and IGF-independent mechanism
39. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
40. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo
41. Insulin-like growth factor binding proteins
42. Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breast cancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation
43. Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells
44. Identification of the insulin-like growth factor binding proteins 5 and 6 (IGFBP-5 and 6) in human breast cancer cells
45. Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells
46. TGF-α and TGF-β expression during sodium-n-butyrate-induced differentiation of human keratinocytes: Evidence for subpopulation-specific up-regulation of TGF-β mRNA in suprabasal cells
47. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene
48. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals
49. Butyrate and the colonocyte. Production, absorption, metabolism, and therapeutic implication
50. Generation and characterization of IGFBP-7 antibody: Identification of 31 kD IGFBP-7 in human biological fluids and Hs578T human breast cancer conditioned media
51. Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo
52. Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-β in Hs578T cells
53. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A
54. Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines